|
2026
|
Invention
|
Method of treating psma-expressing cancers.
The present invention relates to combinations for us... |
|
2025
|
Invention
|
Methods for preparing psma conjugates.
This disclosure relates to processes for preparing compou... |
|
|
Invention
|
Methods of use for car t cells.
The present disclosure relates to methods of treating a patient ... |
|
2024
|
Invention
|
Methods of treating cancer.
The invention described herein pertains to drug delivery conjugates ... |
|
|
Invention
|
Sequencing method for car t cell therapy.
The present disclosure relates to methods of treating ... |
|
|
Invention
|
Methods and compositions for car t cell therapy.
The present disclosure relates to methods of tr... |
|
|
Invention
|
Compounds for positron emission tomography.
Described herein are compounds, compositions, and me... |
|
|
Invention
|
Conjugates for treating diseases caused by psma expressing cells.
The invention described herein... |
|
|
Invention
|
Methods of treating cancer by targeting tumor-associated macrophages.
Methods for treating cance... |
|
2023
|
Invention
|
Compositions and methods for car t cell therapy.
The present disclosure relates to methods of tr... |
|
|
Invention
|
Methods of use for car t cells. The present disclosure relates to methods of treating a patient w... |
|
2021
|
Invention
|
Compounds for positron emission tomography. Described herein are compounds, compositions, and met... |
|
|
Invention
|
Methods of controlling acute inflammatory response. The present disclosure relates to composition... |
|
|
Invention
|
Method of treating psma-expressing cancers. The present invention relates to combinations for use... |
|
2020
|
Invention
|
Antifolate conjugates for treating inflammation.
The present invention relates to compositions a... |
|
|
Invention
|
Compositions and methods for car t cell therapy. The present disclosure relates to methods of tre... |
|
|
Invention
|
Conjugates containing hydrophilic spacer linkers.
Described herein are compositions and methods ... |
|
|
Invention
|
Methods for preparing psma conjugates. This disclosure relates to processes for preparing compoun... |
|
|
Invention
|
Bivalent linkers and conjugates thereof.
Bivalent linkers to be included in or for preparing vit... |
|
|
Invention
|
Conjugates for treating diseases.
The present disclosure relates to pyrrolobenzodiazepine (PBD) ... |
|
2019
|
Invention
|
Vitamin receptor drug delivery conjugates for treating inflammation.
Described herein are compos... |
|
|
Invention
|
Methods of treating cancer.
The disclosure pertains to drug delivery conjugates for targeted the... |
|
|
Invention
|
Methods of treating cancer. The disclosure pertains to drug delivery conjugates for targeted ther... |
|
|
Invention
|
Shielding agents and their use.
The present disclosure relates to compounds useful as shielding ... |
|
|
Invention
|
Shielding agents and their use. The present disclosure relates to compounds useful as shielding a... |
|
|
Invention
|
Drug delivery conjugates containing unnatural amino acids and methods for using.
Described herei... |
|
|
Invention
|
Bivalent linkers and conjugates thereof. This invention pertains to bivalent linkers, and the syn... |
|
|
Invention
|
Folate receptor binding conjugates of antifolates. Conjugates of antifolates, releasable linkers,... |
|
|
Invention
|
Methods of treating cancer. The invention described herein pertains to drug delivery conjugates f... |
|
|
Invention
|
Sequencing method for car t cell therapy. The present disclosure relates to methods of treating a... |
|
2017
|
Invention
|
Folate conjugate for use in targeting tumor associated macrophages.
Methods are provided for tre... |
|
|
Invention
|
Pbd conjugates for treating diseases.
The present disclosure relates to pyrrolobenzodiazepine (P... |
|
|
G/S
|
Pharmaceuticals; Ethical medicinal preparations; Medicinal healthcare preparations; Chemico-pharm... |
|
2014
|
Invention
|
Compounds for positron emission tomography. or a pharmaceutically acceptable salt thereof, wherei... |
|
2013
|
Invention
|
Drug delivery conjugates, and methods for treating diseases caused by psma expressing cells. Here... |
